![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2020
Canzler, Ulrich; Lueck, Hans-Joachim; Neuser, Petra; Sehouli, Jalid; Burges, Alexander; Harter, Philipp; Schmalfeldt, Barbara; Aminossadati, Behnaz; Mahner, Sven; Kommoss, Stefan; Wimberger, Pauline; Pfisterer, Jacobus; de Gregorio, Nikolaus; Hasenburg, Annette; Gropp-Meier, Martina; El-Balat, Ahmed; Jackisch, Christian; du Bois, Andreas; Meier, Werner und Wagner, Uwe
(2020):
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group.
In: Archives of Gynecology and Obstetrics, Bd. 301, Nr. 5: S. 1267-1274
Pfisterer, Jacobus; Shannon, Catherine M.; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P.; Hein, Alexander; Zeimet, Alain G.; Hanker, Lars C.; Petit, Thierry; Marme, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de Gregorio, Nikolaus; Mahner, Sven; Meniawy, Tarek M.; Park-Simon, Tjoung-Won; Mouret-Reynier, Marie-Ange; Costan, Cristina; Meier, Werner; Reinthaller, Alexander; Goh, Jeffrey C.; L'Haridon, Tifenn; Hay, Sally Baron; Kommoss, Stefan; du Bois, Andreas und Kurtz, Jean-Emmanuel
(2020):
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
In: Lancet Oncology, Bd. 21, Nr. 5: S. 699-709
Hauke, Jan 
ORCID: https://orcid.org/0000-0001-8236-4075; Harter, Philipp; Ernst, Corinna ORCID: https://orcid.org/0000-0001-7756-8815; Burges, Alexander; Schmidt, Sandra; Reuss, Alexander; Borde, Julika; De Gregorio, Nikolaus; Dietrich, Dimo; El-Balat, Ahmed; Kayali, Mohamad; Gevensleben, Heidrun; Hilpert, Felix; Altmüller, Janine; Heimbach, André; Meier, Werner; Schoemig-Markiefka, Birgid; Thiele, Holger; Kimmig, Rainer; Nürnberg, Peter; Kast, Karin; Richters, Lisa; Sehouli, Jalid; Schmutzler, Rita K und Hahnen, Eric ORCID: https://orcid.org/0000-0002-1152-8367
(2020):
Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1/2: results of the observational AGO-TR1 study (NCT02222883).
In: Journal of Medical Genetics, Bd. 59, Nr. 3: S. 248-252
ORCID: https://orcid.org/0000-0001-8236-4075; Harter, Philipp; Ernst, Corinna ORCID: https://orcid.org/0000-0001-7756-8815; Burges, Alexander; Schmidt, Sandra; Reuss, Alexander; Borde, Julika; De Gregorio, Nikolaus; Dietrich, Dimo; El-Balat, Ahmed; Kayali, Mohamad; Gevensleben, Heidrun; Hilpert, Felix; Altmüller, Janine; Heimbach, André; Meier, Werner; Schoemig-Markiefka, Birgid; Thiele, Holger; Kimmig, Rainer; Nürnberg, Peter; Kast, Karin; Richters, Lisa; Sehouli, Jalid; Schmutzler, Rita K und Hahnen, Eric ORCID: https://orcid.org/0000-0002-1152-8367
(2020):
Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1/2: results of the observational AGO-TR1 study (NCT02222883).
In: Journal of Medical Genetics, Bd. 59, Nr. 3: S. 248-252
2019
Hauke, Jan; Hahnen, Eric; Schneider, Stephanie; Reuss, Alexander; Richters, Lisa; Kommoss, Stefan; Heimbach, Andre; Marme, Frederik; Schmidt, Sandra; Prieske, Katharina; Gevensleben, Heidrun; Burges, Alexander; Borde, Julika; De Gregorio, Nikolaus; Nuernberg, Peter; El-Balat, Ahmed; Thiele, Holger; Hilpert, Felix; Altmüller, Janine; Meier, Werner; Dietrich, Dimo; Kimmig, Rainer; Schoemig-Markiefka, Birgid; Kast, Karin; Braicu, Elena Ioana; Baumann, Klaus; Jackisch, Christian; Park-Simon, Tjoung-Won; Ernst, Corinna; Hanker, Lars; Pfisterer, Jacobus; Schnelzer, Andreas; du Bois, Andreas; Schmutzler, Rita K. und Harter, Philipp
(2019):
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
In: Journal of Medical Genetics, Bd. 56, Nr. 9: S. 574-580
[PDF, 705kB]
2018
Chekerov, Radoslav; Hilpert, Felix; Mahner, Sven; El-Balat, Ahmed; Harter, Philipp; De Gregorio, Nikolaus; Fridrich, Claudius; Markmann, Susanne; Potenberg, Jochem; Lorenz, Ralf; Oskay-Oezcelik, Guelten; Schmidt, Marcus; Krabisch, Petra; Lück, Hans-Joachim; Richter, Rolf; Braicu, Elena Ioana; du Bois, Andreas und Sehouli, Jalid
(2018):
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
In: Lancet Oncology, Bd. 19, Nr. 9: S. 1247-1258